These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10415905)

  • 1. Pentamidine is a potent inhibitor of [3H]idazoxan binding to imidazoline I2 receptors.
    Wood DH; Hall JE; Rose BG; Boykin DW; Tidwell RR
    Ann N Y Acad Sci; 1999 Jun; 881():110-3. PubMed ID: 10415905
    [No Abstract]   [Full Text] [Related]  

  • 2. 1,5-Bis(4-amidinophenoxy)pentane (pentamidine) is a potent inhibitor of [3H]idazoxan binding to imidazoline I2 binding sites.
    Wood DH; Hall JE; Rose BG; Tidwell RR
    Eur J Pharmacol; 1998 Jul; 353(1):97-103. PubMed ID: 9721046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of the imidazoline I2b-binding sites in the hamster brown adipose tissue as a study model for imidazoline receptors.
    Römer L; Wurster S; Savola JM; Raasmaja A
    Arch Physiol Biochem; 2003 Apr; 111(2):159-66. PubMed ID: 12919003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.
    Olmos G; Alemany R; Boronat MA; García-Sevilla JA
    Ann N Y Acad Sci; 1999 Jun; 881():144-60. PubMed ID: 10415910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver.
    Remaury A; Ordener C; Shih J; Parini A
    Ann N Y Acad Sci; 1999 Jun; 881():32-4. PubMed ID: 10415894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
    Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of I1 and I2 imidazoline receptors in striatum membranes from different species.
    Vauquelin G; De Backer JP; Ladure P; Flamez A
    Ann N Y Acad Sci; 1999 Jun; 881():135-43. PubMed ID: 10415909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]idazoxan binds to mitochondrial I2 imidazoline binding sites in isolated cells from rabbit kidney proximal tubule.
    Gargalidis-Moudanos C; Parini A
    Ann N Y Acad Sci; 1995 Jul; 763():172-3. PubMed ID: 7677328
    [No Abstract]   [Full Text] [Related]  

  • 11. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of imidazoline I2 binding sites in pig brain.
    Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
    Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased density of I2-imidazoline receptors in human glioblastomas.
    Martín-Gómez JI; Ruiz J; Callado LF; Garibi JM; Aguinaco L; Barturen F; Javier Meana J
    Neuroreport; 1996 May; 7(8):1393-6. PubMed ID: 8856683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.
    Escribá PV; Alemany R; Sastre M; Olmos G; Ozaita A; García-Sevilla JA
    Br J Pharmacol; 1996 Aug; 118(8):2029-36. PubMed ID: 8864539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [3H]-RS-45041-190: a selective high-affinity radioligand for I2 imidazoline receptors.
    MacKinnon AC; Redfern WS; Brown CM
    Br J Pharmacol; 1995 Sep; 116(2):1729-36. PubMed ID: 8528552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do alpha 2-adrenoceptors and imidazoline binding sites coexist in the human term placenta? Evidence from direct binding studies.
    Bagaméry K; Kovács L; Nyári T; Falkay G
    Mol Hum Reprod; 1998 Apr; 4(4):387-91. PubMed ID: 9620839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation.
    Regunathan S; Youngson C; Raasch W; Wang H; Reis DJ
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1272-82. PubMed ID: 8786560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.